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Biology of PrPsc accumulation in two natural scrapie-infected
sheep flocks
Patrick Caplazi, Katherine O’Rourke, Cynthia Wolf, Daniel Shaw, Timothy V. Baszler1
Abstract. Sheep scrapie is a prion disease that requires interaction of exogenous prions with host prion
protein (PrP) supporting prion formation. Disease is associated with deposition of a host-generated conformational variant of PrP, PrPsc, in a variety of tissues, including brain, resulting in fatal spongiform encephalopathy.
Efficiency of PrPsc formation is determined by polymorphisms in the PrP-coding sequence. This article adds to
previous data of natural sheep scrapie, concentrating on the effect of host genotype and age on PrPsc accumulation patterns during preclinical and clinical disease. Two entire scrapie-infected, predominantly Suffolk-cross,
sheep flocks euthanized for regulatory purposes were genotyped and analyzed for PrPsc deposition in various
tissues using single- and dual-label immunohistochemistry. Scrapie, as defined by PrPsc deposition, occurred in
13/80 sheep. Preclinical disease was evident in nearly 70% of infected sheep, ranging in age from 14 months
to 7 years. PrPsc accumulated systemically in the nervous tissue, various lymphoid tissues, both alimentary tract
related and non–alimentary tract related, and the placenta. Clinical neurological illness was always associated
with spongiform encephalopathy and PrPsc deposition in the brain. Only 6 of 9 sheep with preclinical scrapie
had PrPsc deposition in the brain but widespread PrPsc deposition in peripheral lymphoid tissue, supporting
previous data showing peripheral PrPsc accumulation preceding deposition in the brain. PrPsc colocalized with
a marker for follicular dendritic cells throughout the lymphoid system. PrPsc also accumulated in the peripheral
nervous system, particularly the nervous supply of the gastrointestinal tract. Abundant PrPsc was evident in
trophoblast cells of placentomes but not in the endometrium, myometrium, or associated nervous plexus. PrPsc
deposits were not observed in the mammary parenchyma or bone marrow. Scrapie susceptibility was defined
genetically by PrP codon 171: PrPsc deposition was restricted to PrP genotype AA136RR154QQ171 in 12/13 cases
or AV136RR154QQ171 in 1/13 cases. The earliest accumulation was observed in the single VRQ/ARQ heterozygous
animal, consistent with the reported high scrapie susceptibility and brief incubation period observed in breeds
with predominance of the V136R154Q171 allele. Disease occurred within, as well as independent of, mother–
daughter lines, suggesting both maternal and nonmaternal transmission in the flocks.

Introduction
Scrapie is the prototype of those transmissible spongiform encephalopathies (TSE) with a combined infectious and genetic pathogenesis and occurs naturally
in sheep and goats.10–12 The importance of oral uptake
of infectious material for transmission12,29,30 and the
contribution of lymphoid tissue related to the alimentary tract for local amplification of PrPsc, a conformational variant of prion protein (PrP), have been recognized12,18 and is supported by experimental models.3,4 Data indicate that scrapie generally follows oral
uptake of prions and includes a preclinical phase characterized by local amplification of PrPsc in the lym-

phoid tissue of the alimentary tract and transport
through the peripheral nervous system into the central
nervous system (CNS).8,13,14 PrPsc accumulation patterns vary greatly among prion diseases, and susceptibility to scrapie is greatly modified by polymorphisms in the PrP gene, PRNP. This article, in support
of previous reports, describes the biology of natural
scrapie in 2 sheep flocks with specific reference to the
tissue and cellular topography of PrPsc during preclinical and clinical disease, the role of host genotype in
disease incubation, and potential modes of agent transmission.
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Animals and selection of tissue samples. Sheep (n 5 80)
from 2 privately owned flocks were euthanized and necropsied for disease regulatory purposes after observation of index clinical scrapie cases. Flock A, containing 50 sheep,
originated from North Central United States, and flock B,
containing 30 sheep, originated from the Pacific Northwest
United States. Both flocks consisted predominately of Suffolk (n 5 51) or Suffolk-cross sheep (n 5 22), with the
remainder being Black desert (n 5 3) or White desert (n 5
4). Sheep ranged in age from 12 mo to .6 yr, the majority

Materials and methods
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Table 1.

Age distribution of PrPsc and disease status in 2 scrapie-infected flocks.
PrPsc positive†

PrPsc negative*

Preclinical

Clinical

Age

n

% total‡

Similar age
(%)§

n

% total

Similar age
(%)

n

% total

Similar age
(%)

#14 mo
2 yr
3 yr
4 yr
5 yr
$6 yr
Total

45
4
7
6
3
2
67

56.25
5.00
8.75
7.50
3.75
2.50
83.75

98
50
63.6
75
75
66.6
NA\

0
0
1
2
1
0
4

0
0
1.25
2.5
1.25
0
5.0

0
0
9
25
25
0
NA

1
4
3
0
0
1
9

1.25
5.0
3.75
0
0
1.25
11.25

2
50
36.3
0
0
33.3
NA

* No PrPsc immunoreactivity in any tissue.
† PrPsc immunoreactivity in at least 1 tissue.
‡ Percentage of total number of sheep in 2 flocks.
§ Percentage of number of sheep of similar age.
\ NA 5 not applicable.

being #2 yr old (n 5 54). Information on clinical signs and
familial lineage was collected for individual sheep.
Various tissues were collected postmortem and fixed in
10% formalin for analysis of microscopic lesions by histopathology and PrPsc deposition by immunohistochemistry.
Anatomic sites of tissues for PrPsc immunohistochemistry
were 1) CNS (brain), 2) alimentary tract (jejunum, ileum,
colon, rectum) and related lymph nodes, 3) lymphoid system
not related to the alimentary tract (third eyelid, spleen, and
various lymph nodes [superficial cervical, subiliac, medial
iliac]), 4) mammary gland and related lymph node, 5) hematopoietic tissues (bone marrow), and 6) reproductive/fetal
tissues (uterus, placenta, fetal spleen, fetal ileum).
Determination of PrP genotype. Whole blood was collected for isolation of genomic DNA from the leukocyte
fraction. Amino acid polymorphisms at PrP codons 136, 154,
and 171 were determined by DNA sequencing using commercially available services.a,b DNA sequencing followed
PCR amplification using primers specific for the entire PrPcoding sequence, as described previously.38
Immunohistochemical detection of PrPsc. Single-label immunohistochemistry for PrPsc was performed on formalinfixed, paraffin-embedded tissues using heat-induced antigen
retrieval and 90% formic acid pretreatment as described previously.25 F89.160.1.5 (F89), a monoclonal antibody (mAb)
to ruminant PrP targeting a conserved epitope at residues
142 through 145 of ovine PrP,26 was used at a concentration
of 1 mg/ml in a labeled streptavidin-biotin–based system.c
Amino-ethyl-carbazole (AEC) was used as a chromogen.d
Positive control tissue, consisting of brain or lymph node
from a known scrapie-positive sheep, was included in each
run to confirm immunoreactivity of the appropriate pattern
and intensity in lymphoid follicle germinal centers and in
the neuropil of the brain as described previously.26,27 Negative controls consisted of a negative antibody control and a
negative tissue control. Negative antibody was an irrelevant
isotype-matched primary antibody (anti–Neospora caninum
mAb Nc-5B6-25, 1 mg/ml) reacted with each test slide to
ensure the lack of nonspecific binding by linker or signal
amplification reagents to tissue sections. Negative tissue

control consisted of brain and lymph node of a known scrapie-negative sheep reacted with anti-PrP mAb F89 to ensure
absence of PrPsc immunoreactivity.
Conditions of antigen retrieval and pretreatment procedures were adapted for dual immunohistochemistry using
antibodies toward cell-specific markers in conjunction with
F89 for PrPsc. Antibodies toward cell markers included mAb
CNA.42 for follicular dendritic cells (FDCs),e anti-CD3 rabbit antiserum for T lymphocytes,d anti-CD79a mAb for B
lymphocytes,e anti–neuron-specific enolase rabbit antiserum
for ganglion cells,d and mAb NCL-LN5 for macrophage/
monocytes.f Dual labeling was carried out sequentially using
cell-specific antibodies with peroxidase-based color reaction
(red) in the first sequence and F89 with alkaline phosphatase–based color reaction (black) in the second sequence.
After development of the red signal (AEC) under microscopic control, slides were incubated with 0.3 M glycine HCl
at pH 1.8 at room temperature overnight to denature potential binding sites on linker reagents from the first sequence;
then, residual biotin binding was blocked with an avidinbiotin–blocking kit.g As a control for the efficacy of blocking
steps between sequences (i.e., nonspecific staining of the
second immunostaining sequence), slides were treated with
the full first sequence except for the color reaction and then
subjected to the blocking steps and the full second sequence
omitting primary antibody incubation. Absence of black signal (second signal) in these slides indicated effectiveness of
disruptive glycine HCl treatment and avidin–biotin block between the sequences and, thus, absence of cross-reactivity
between the 2 sequences (i.e., black signal represented PrPsc
without cross-reactivity with cell markers).

Results
Age distribution of PrPsc accumulation. Age of the
sheep ranged from 12 months to 7 years of age; 67%
of sheep were 24 months or younger (Table 1). Scrapie, as defined by neural or extraneural deposition of
PrPsc, was diagnosed in 13 of 80 sheep (16.25%),
whereas 67 of 80 sheep (83.75%) had no detectable
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Table 2.
Tissue*

Central nervous system
Brain
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Tissue distribution of PrPsc immunoreactivity in PrPsc-positive sheep.
Total†

% total

Clinical‡

Preclinical§

10/13

77

4/4

6/9

Alimentary tract and related lymphoid tissues
Jejunum
7/13
Ileum
12/13
Colon
12/13
Rectum
9/12
Medial iliac LN
13/13
Anorectal LN
9/11
Palatine tonsil
12/12
Retropharyngeal LN
13/13

54
92
92
75
100
82
100
100

3/4
4/4
4/4
3/4
4/4
2/2
4/4
4/4

4/9
8/9
8/9
6/8
9/9
7/9
8/8
9/9

Lymphoid tissues not related to alimentary tract
Third eyelid
12/13
Spleen
9/9
Subiliac LN
10/11

92
100
91

4/4
3/3
4/4

8/9
6/6
6/7

Mammary gland and related LN
Mammary gland
Mammary LN

8
100

1/4\
4/4

0/9
8/8

1/13\
12/12

Hematopoietic
Bone marrow

0/13

0

0/4

0/9

Reproductive/fetal
Placenta
Uterus
Fetal spleen
Fetal ileum

8/9
0/13
0/2
0/2

89
0
0
0

2/3
0/4

6/6
0/9

* LN 5 lymph node.
† Sheep with PrPsc-positive tissue/total sheep examined.
‡ Clinical scrapie sheep with PrPsc-positive tissue/total clinical scrapie sheep examined.
§ Preclinical scrapie sheep with PrPsc-positive tissue/total preclinical scrapie sheep examined.
\ PrPsc deposits restricted to the germinal center of an interstitial lymphoid follicle.

PrPsc in any tissue. Sheep with PrPsc deposits ranged
from 14 months to more than 6 years. Disease occurred in 12 of 34 sheep aged $2 years or 12 of 18
genetically susceptible sheep aged $2 years, indicating
high disease prevalence in this age category of 43 or
67%, respectively.
Clinical neurological disease typical of scrapie was
observed in 4 of the 13 sheep with PrPsc deposits. PrPsc
deposits and spongiform lesions were widespread
within the 4 coronal planes examined (brain stem at
the obex, middle cerebellar peduncle, rostral mesencephalic colliculi, and thalamus). The remaining 9
sheep with PrPsc deposits were preclinical and ranged
in age from 14 months to more than 6 years.
Tissue distribution of PrPsc deposition. PrPsc deposits were widespread in all scrapie-infected sheep (Table 2). Detection of PrPsc in non–central nervous tissues was biased by the density of lymphoid follicles
in the examined sample. For example, deposits were
more frequently observed in ileum and colon (12 of
13 samples) than in rectum and jejunum (7 of 13 and
9 of 12 samples, respectively).

PrPsc deposits in the brain were detected in all (4 of
4) clinical sheep, but only in 6 of 9 preclinical sheep.
Central nervous deposits were thus less frequent (10
of 13; 77% of affected sheep) than alimentary tract–
related deposits (13 of 13; 100%). Deposits in extraneural tissue always accompanied PrPsc deposits in the
brain.
PrPsc deposits were generalized in alimentary tract–
associated and non-alimentary tract–associated lymphoid tissue. PrPsc deposits occurred in the placentas
of 8 of 9 scrapie-infected sheep that were pregnant. Of
the 8 placenta-positive ewes, 6 were preclinical, 2 of
which were without deposits in the brain. PrPsc was
not detected in the bone marrow, secretory parenchyma of the mammary gland, uterus, or fetus of any scrapie-infected sheep.
Cellular distribution of PrPsc deposition. In lymphoid tissues, PrPsc deposits were localized to the germinal centers of lymphoid follicles in a random, multifocal pattern (Fig. 1A). Cells that accumulated PrPsc
in lymphoid tissues were similar regardless of the anatomical location of the lymphoid tissue. The intensity
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Figure 1. Microanatomic distribution of PrPsc accumulation in sheep with clinical and preclinical scrapie detected by single- and duallabel immunohistochemistry. A, ileum (preclinical). Multifocal, coarsely granular deposits of PrPsc (arrows) in the germinal center of a gutassociated lymphoid follicle (G) subjacent to intestinal crypts (C). PrPsc deposits were not detected in intestinal epithelium. Single-label
immunohistochemistry using F89 mAb–red. 1003. B, retropharyngeal lymph node (clinical). Multifocal PrPsc accumulation (black) in the
germinal center (G) of a lymphoid follicle; no immunoreactivity in the mantle zone (M). PrPsc (black) mostly colocalized with dendrites
and cell bodies of FDCs (red). Dual-label immunohistochemistry using mAbs CNA.42-red (FDC) and F89-black (PrPsc). 4003. C, mes-
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Table 3.
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PrP genotype frequency of PrPsc and disease status in 2 scrapie-infected flocks.

Genotype

PrPsc negative

PrPsc positive

Clinical

Preclinical

AA136RR154QQ171
AA136RR154QR171
AA136RR154RR171
AA136RH154QQ171
AV136RR154QQ171
AV136RR154QR171

34
27
2
1
1
2

12
0
0
0
1
0

4
0
0
0
0
0

8*
0
0
0
1†
0

* PrPsc positive at $24 mo of age.
† PrPsc positive at 14 mo of age.

of immunoreactivity varied among individual sheep
but did not correlate with age or clinical status. Most
immunoreactivity was detected in multipolar cells
characteristic of FDCs (Fig. 1B). Using dual-label immunohistochemistry, detecting specific cellular markers and PrPsc, PrPsc colocalized with CNA.42, a marker
specific for FDC (Fig. 1B, 1C).19,22,33 PrPsc did not colocalize with CD3, a marker for T lymphocytes (Fig.
1E), or CD79a, a B-lymphocyte marker (Fig. 1F).
Rarely, PrPsc colocalized with a macrophage marker
(NCL-LN5) in macrophages in the medulla of lymph
nodes but not within germinal center macrophages (not
shown).
PrPsc deposition in nonlymphoid tissues (outside the
CNS) was restricted to neurons and chorionic epithelium. In the gut, PrPsc was regularly detected within
the perikarya and neurites of the submucosal and myenteric plexus, colocalizing with neuron-specific enolase, a marker for neural cells (Fig. 1D). Axonal and
somatic PrPsc deposits were also detected in the mesenteric ganglia (not shown). No PrPsc deposits were
detected in gut epithelial cells, including M cells of
Peyer’s patches, smooth muscle cells, endothelial cells,
or round cells in the lamina propria. Placental PrPsc
deposition was present multifocally in placentomes
within groups of chorionic epithelial cells of the cotyledon but not within adjacent endometrial epithelial
cells of the interdigitating maternal caruncle (Fig. 1G).
The deposits were present within the cytoplasm of

chorionic mononuclear and multinuclear trophoblast
cells (as identified by morphology) and were apparently not cell associated in the space between the fetal
cotyledon and the maternal caruncle (Fig. 1H). In the
brain, PrPsc deposits were associated with glial cells
and neurons within various nuclei of the diencephalon,
mesencephalon, metencephalon, and myelencephalon.
Detailed, scrapie strain–specific topography of central
nervous PrPsc deposits has been reported9 and was not
the subject of this study.
Effect of PrP genotype on scrapie status of the
sheep. All PrPsc-positive sheep were homozygous for
glutamine at codon 171 and homozygous for arginine
at codon 154 of the PrP gene (RR154QQ171) (Table 3).
One PrPsc-positive sheep was heterozygous for alanine
and valine at codon 136 (AV136), whereas the remaining 12 PrPsc-positive sheep were homozygous for alanine (AA136). Thus, 12/13 PrPsc-positive sheep were
genotype AA136RR154QQ171 and 1/13 was genotype
AV136RR154QQ171. Consistent with published data on
the effect of genotype on susceptibility and incubation
period,16,28 the single PrPsc-positive AV136RR154QQ171
sheep was younger (14 mo) than the 4 youngest PrPscpositive AA136RR154QQ171 sheep (24 months). Tissue
distribution, cell specificity, or intensity of PrPsc deposition did not differ between genotypes. Representation in the study was good for PrP genotypes AA136
(76/80), QQ171 (49/80), and QR171 (29/80), whereas genotypes AV136 (4/80), VV136 (0/80), RH154 (1/80),

←
enteric lymph node (preclinical). Higher magnification of PrPsc (black) colocalized (arrows) with dendrites and cell bodies of FDCs (red).
Dual-label immunohistochemistry using CNA.42-red (FDC) and F89 mAb–black (PrPsc). 6303. D, ileum (clinical). Finely granular deposits
of PrPsc (black) occur throughout the myenteric plexus (red). Colocalization (arrows) of PrPsc (black) with nerve fibers of the myenteric
plexus (red). Dual-label immunohistochemistry using anti-neuron-specific enolase–red (ganglia neurons and fibers) and F89 mAb–black
(PrPsc). 1003. E, medial iliac lymph node germinal center (clinical). PrPsc deposits (black) do not colocalize with T lymphocytes (red) that
are sparsely scattered throughout the germinal center (G) or packed within the adjacent paracortex (P). Dual-label immunohistochemistry
using anti-CD3–red (T-lymphocyte) and F89 mAb–black (PrPsc). 4003. F, subiliac lymph node germinal center (clinical). PrPsc (black)
does not colocalize with B lymphocytes (red) in the germinal center (G). Dual-label immunohistochemistry using anti-CD79a–red (B-cell)
and F89 mAb–black (PrPsc). 4003. G, placenta (placentome) (clinical). PrPsc (red) localized to chorionic epithelium of the fetal cotyledon
(arrows). No immunoreactivity of maternal caruncle epithelium (M). Single-label immunohistochemistry using F89 mAb–red (PrPsc). 2003.
H, placenta (placentome) (clinical). PrPsc (red) localized to the cytoplasm of mononuclear and multinuclear chorionic epithelial cells of the
fetal cotyledon (arrows). Some immunoreactivity free in the extracellular space between fetal cotyledon and maternal caruncle (arrowhead).
Single-label immunohistochemistry using F89 mAb–red (PrPsc). 6303.

494

Caplazi et al.

HH154 (0/80), and RR171 (2/80) were underrepresented
(Table 3).
Potential modes of transmission. Potential modes of
scrapie transmission were investigated by analyzing
genealogy within flock A and by examining fetuses
and offspring of PrPsc-positive sheep when available.
Association of clinical scrapie with PrPsc-positive status by genealogy was not possible in all PrPsc-positive
sheep. Not all sheep culled or removed from the flocks
because of wasting of suspect scrapie were necropsied
to definitively determine scrapie status. However, in 7/
13 PrPsc-positive sheep, in which accurate genealogy
analysis was possible, positive scrapie status followed
mother-to-daughter lineage in 57% (4/7) and was not
associated with mother-to-daughter lineage in 43% (3/
7). The single 7-year-old sheep with preclinical scrapie
was part of the latter group. Two fetuses from PrPscpositive ewes with clinical scrapie were available for
examination. Both ewes had PrPsc deposition in the
placenta, proving the scrapie-susceptible genotype of
the fetus,36 but neither fetus had PrPsc deposition in
fetal spleen or intestine (Table 2).
Discussion
This study demonstrates the spatial and cell-specific
preclinical accumulation pattern of PrPsc in sheep that
resemble in their PrP genotype the American Suffolk,
a breed with limited PrP gene polymorphism and prolonged preclinical phase. As expected from experimental models,4,5,23 a buildup of PrPsc throughout the
lymphoid system can be observed during the preclinical period after a lag phase during which PrPsc is not
detectable by immunohistochemistry. After the lag
phase, PrPsc accumulates rapidly in lymphoid tissues
throughout the body as well as the intestinal nervous
supply, which offers the possibility of biopsy-based
preclinical diagnosis.24,25,34,35 On the other hand, preclinical dissemination of PrPsc deposits into the placenta indicates a risk of horizontal and vertical transmission by clinically healthy ewes. The finding that
most cases within scrapie-affected flocks are preclinical underscores the significance of observing PrPsc accumulation in the placentas of a high percentage of
infected sheep.
Based on this study, the lag phase needed for PrPsc
deposits to become detectable by immunohistochemistry is about 12–14 months, assuming perinatal infection by oral exposure to PrPsc. This lag phase is longer
in Suffolk-type sheep with predominance of the
A136R154Q171 allele than the 2–6 months reported in
breeds with predominance of the V136R154Q171 allele.1,21,35 The data thus support the notion that the primary structure of PrP determines the rate of PrPsc accumulation. From this it follows that the residues at
positions 136 and 171 determine disease susceptibility

by altering accumulation kinetics rather than accumulation sites or cellular specificity. Further research
is needed to determine the nature of this kinetic barrier
and whether parameters such as time and infectious
dose modify its permissibility to accumulation and disease.
PrPsc was identified in FDCs and peripheral neurons.
PrPsc was only rarely detected in macrophages. Scant,
macrophage-associated PrPsc was occasionally detected in the medulla of lymph nodes, rather than in the
germinal centers of lymphoid follicles. This observation contrasts somewhat to a similar study that reports
early accumulation of PrPsc in tingible body macrophages of the germinal center.17 Failure to observe
PrPsc in tingible body macrophages may be because of
examination of tissues at a later stage of disease because PrPsc derives from scavenging exogenous PrPsc
rather than synthesis within that cell type.15
The distribution of PrPsc observed in this study underscores the importance of the germinal center and
FDC for the peripheral amplification of PrPsc and is
consistent with neurogenic spread from sites of primary amplification to the CNS. Our observations support the role of FDC for scrapie pathogenesis6 and are
in line with experiments that report drastically reduced
susceptibility of mice to scrapie on dedifferentiation of
FDC.20 Furthermore, the proximity of nerve endings
and PrPsc in lymphoid follicles has been demonstrated.14,31 Conversely, in this study the authors failed to
observe a pattern of PrPsc accumulation in lymphoid
tissues that would suggest travel of PrPsc through the
lymphatic vessels or blood stream. For instance, PrPsc
was not detected in the glandular tissue of the mammary gland, the tributary region of the mammary
lymph nodes; yet, the mammary lymph node regularly
accumulated PrPsc. Likewise, PrPsc was not detected in
the bone marrow or splenic red pulp and was only
rarely detected in macrophages within lymph nodes.
The mode by which generalized depositional disease
throughout the lymphoid tissue is initiated and synchronized has been elusive; however, episodic hematogenous dispersion of cells carrying PrPsc below the
detection level of immunologic assays is a possibility.
Large, intrauterine PrPsc deposits occurred during
preclinical and clinical disease and were restricted to
the (fetal) chorionic epithelium of the placentome,
whereas no PrPsc was detected in adjacent maternal
tissues or tissues of the fetus proper. This observation
is consistent with the well-recognized infectivity of fetal membranes.32 Similar to Andreoletti et al.,2 PrPsc
was found to be restricted to fetal tissues. Because
placentomes were not analyzed specifically for macrophages, the possibility of PrPsc deposits occurring in
macrophages of the (maternal) caruncle or at the interface between fetal and maternal tissues remains.

Biology of natural sheep scrapie

The finding of Andreoletti et al.2 is in contrast to those
of Tuo et al.,37 who observed PrPsc deposits also in the
caruncular epithelium, albeit the latter study did not
use double immunohistochemistry to ascertain cellular
specificity
Natural transmission of sheep scrapie is thought to
occur most commonly by perinatal maternal transmission through oral exposure of neonates to prions within
the secundines and placental fluids,7,32 a mechanism
supported by the findings of this study. Infection of
placental membranes is reportedly restricted to susceptible fetal genotypes.36 In this study, transmission followed ewe-to-lamb lines in most scrapie-affected
sheep, and there was abundant PrPsc deposition within
and around placental trophoblast cells. PrPsc was not
evident in 2 genetically susceptible fetuses, supporting
other studies arguing against direct intrauterine transmission of scrapie or infectivity of the fetus proper.2,12
However, horizontal transmission is reported to occur
in heavily infected flocks.39 Similarly, this study
showed transmission outside the ewe-to-lamb lines in
43% of cases; for example, preclinical scrapie was diagnosed in a 7-year-old ewe. Understanding how PrP
polymorphism affects PrP conversion and PrPsc deposition in specific tissues and cell types, especially those
at potential sites of preclinical accumulation, is critical
to the development of treatment or control measures
for the scrapie-type TSE.
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